Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
DXFO0F
|
||||
Drug Name |
(S)-N-((R)-2-(benzyloxy)-1-cyanoethyl)-4-methyl-2-(2-(2-methyl-1H-imidazol-1-yl)acetamido)pentanamide
|
||||
Synonyms |
CHEMBL208253
|
||||
Indication | Discovery agent | Investigative | [1587926] | ||
Formula |
C22H29N5O3
|
||||
Canonical SMILES |
CC(C)C[C@H](NC(=O)Cn1ccnc1C)C(=O)N[C@@H](COCc2ccccc2)C#N
|
||||
InChI |
InChI=1S/C22H29N5O3/c1-16(2)11-20(26-21(28)13-27-10-9-24-17(27)3)22(29)25-19(12-23)15-30-14-18-7-5-4-6-8-18/h4-10,16,19-20H,11,13-15H2,1-3H3,(H,25,29)(H,26,28)/t19-,20+/m1/s1
|
||||
InChIKey |
FSIREUUIWZPQTN-UXHICEINSA-N
|
||||
Target and Pathway | |||||
Target(s) | Cathepsin K | Target Info | [1587926] | ||
Cathepsin L | Target Info | [1587926] | |||
Reactome | Collagen degradation | ||||
Degradation of the extracellular matrix | |||||
Activation of Matrix Metalloproteinases | |||||
Trafficking and processing of endosomal TLR | |||||
MHC class II antigen presentationR-HSA-1236977:Endosomal/Vacuolar pathway | |||||
Assembly of collagen fibrils and other multimeric structures | |||||
MHC class II antigen presentation | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.